SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging
Wioletta Rut(Wrocław University of Science and Technology), Katarzyna Groborz(Wrocław University of Science and Technology), Linlin Zhang(German Center for Infection Research), Xinyuanyuan Sun(German Center for Infection Research), Mikołaj Żmudziński(Wrocław University of Science and Technology), Bartłomiej Pawlik(Medical University of Warsaw), Xinyu Wang(Rega Institute for Medical Research), Dirk Jochmans(Rega Institute for Medical Research), Johan Neyts(Rega Institute for Medical Research), Wojciech Młynarski(Medical University of Lodz), Rolf Hilgenfeld(German Center for Infection Research), Marcin Drąg(Wrocław University of Science and Technology)
Cited by 326Open Access
Abstract
Related Papers
Features and development of <i>Coot</i>
Paul Emsley, Bernhard Lohkamp, W. G. Scott et al.|Acta Crystallographica Section D Biological Crystallography|2010|29.4k
Overview of the<i>CCP</i>4 suite and current developments
Martyn Winn, Charles Ballard, Kevin Cowtan et al.|Acta Crystallographica Section D Biological Crystallography|2011|12.5k
<i>REFMAC</i>5 for the refinement of macromolecular crystal structures
Garib N. Murshudov, Pavol Skubák, Andrey A. Lebedev et al.|Acta Crystallographica Section D Biological Crystallography|2011|8.6k
Scaling and assessment of data quality
Philip Evans|Acta Crystallographica Section D Biological Crystallography|2005|4.5k